Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC)

1. Maroto, J.P.
2. Del Muro, X.G.
3. Mellado, B.
4. Perez-Gracia, J.L.
5. Andrés, R.
6. Cruz, J.
7. Gallardo, E.
8. Domenech, M.
9. Arranz, J.A.
10. Meana, J.A.